30. P. Lassalas, B. Gay, C. Lasfargeas, M. J. James, V. Tran, K. G. Vijayendran, K. R.
Brunden, M. C. Kozlowski, C. J. Thomas, A. B. Smith 3rd, D. M. Huryn, C.
Ballatore, Structure property relationships of carboxylic acid isosteres. J. Med.
31. J. Schmidt, J. Choi, A. T. Liu, M. Slusarczyk, G. C. Fu, A general, modular method
for the catalytic asymmetric synthesis of alkylboronate esters. Science 354,
32. Y. Xi, J. F. Hartwig, Diverse asymmetric hydrofunctionalization of aliphatic
internal alkenes through catalytic regioselective hydroboration. J. Am. Chem.
33. G. A. Molander, N. Ellis, Organotrifluoroborates: Protected boronic acids that
expand the versatility of the Suzuki coupling reaction. Acc. Chem. Res. 40, 275–
34. S. N. Mlynarski, A. S. Karns, J. P. Morken, Direct stereospecific amination of alkyl
and aryl pinacol boronates. J. Am. Chem. Soc. 134, 16449–16451 (2012).
35. A. Bonet, M. Odachowski, D. Leonori, S. Essafi, V. K. Aggarwal, Enantiospecific
sp2-sp3 coupling of secondary and tertiary boronic esters. Nat. Chem. 6, 584–
36. S. Laulhé, J. M. Blackburn, J. L. Roizen, Selective and serial Suzuki-Miyaura
reactions of polychlorinated aromatics with alkyl pinacol boronic esters. Org.
37. V. M. Dembitsky, M. Srebnik, Synthesis and biological activity of α-aminoboronic
acids, amine-carboxyboranes and their derivatives. Tetrahedron 59, 579–593
47. F. von Nussbaum, V. M.-J. Li, S. Allerheiligen, S. Anlauf, L. Bärfacker, M. Bechem,
M. Delbeck, M. F. Fitzgerald, M. Gerisch, H. Gielen-Haertwig, H. Haning, D.
Karthaus, D. Lang, K. Lustig, D. Meibom, J. Mittendorf, U. Rosentreter, M.
Schäfer, S. Schäfer, J. Schamberger, L. A. Telan, A. Tersteegen, Freezing the
bioactive conformation to boost potency: The identification of BAY 85-8501, a
selective and potent inhibitor of human neutrophil elastase for pulmonary
48. F. O. Gombert et al., patent application WO2015096873 (2015).
49. T. J. Blench et al., patent application WO2013037809 (2013).
50. L. Bergström, M. Lundkvist, H. Lönn, P. Sjö, patent application WO2008030158
(2008).
51. M. D. Shultz, The thermodynamic basis for the use of lipophilic efficiency (LipE) in
enthalpic optimizations. Bioorg. Med. Chem. Lett. 23, 5992–6000 (2013).
52. A. Zervosen, R. Herman, F. Kerff, A. Herman, A. Bouillez, F. Prati, R. F. Pratt, J.-M.
Frère, B. Joris, A. Luxen, P. Charlier, E. Sauvage, Unexpected tricovalent binding
mode of boronic acids within the active site of a penicillin-binding protein. J. Am.
53. M. Groll, C. R. Berkers, H. L. Ploegh, H. Ovaa, Crystal structure of the boronic
acid-based proteasome inhibitor bortezomib in complex with the yeast 20S
54. A. F. Kisselev, W. A. van der Linden, H. S. Overkleeft, Proteasome inhibitors: An
expanding army attacking a unique target. Chem. Biol. 19, 99–115 (2012).
55. M. D. Greenhalgh, S. P. Thomas, Chemo-, regio-, and stereoselective iron-
catalysed hydroboration of alkenes and alkynes. Chem. Commun. 49, 11230–
38. J. J. McAtee, S. L. Castle, Q. Jin, D. L. Boger, Synthesis and evaluation of
vancomycin and vancomycin aglycon analogues that bear modifications in the
residue
3 asparagine. Bioorg. Med. Chem. Lett. 12, 1319–1322 (2002).
56. Y. Wen, J. Xie, C. Deng, C. Li, Selective synthesis of alkylboronates by copper(I)-
catalyzed borylation of allyl or vinyl arenes. J. Org. Chem. 80, 4142–4147 (2015).
57. S. Roesner, C. A. Brown, M. Mohiti, A. P. Pulis, R. Rasappan, D. J. Blair, S. Essafi,
D. Leonori, V. K. Aggarwal, Stereospecific conversion of alcohols into pinacol
boronic esters using lithiation-borylation methodology with pinacolborane.
58. J. Yi, J.-H. Liu, J. Liang, J.-J. Dai, C.-T. Yang, Y. Fu, L. Liu, Alkylboronic esters from
palladium- and nickel-catalyzed borylation of primary and secondary alkyl
39. F. J. Brown, D. W. Andisik, P. R. Bernstein, C. B. Bryant, C. Ceccarelli, J. R.
Damewood Jr., P. D. Edwards, R. A. Earley, S. Feeney, R. C. Green, B. Gomes, B.
J. Kosmider, R. D. Krell, A. Shaw, G. B. Steelman, R. M. Thomas, E. P. Vacek, C. A.
Veale, P. A. Tuthill, P. Warner, J. C. Williams, D. J. Wolanin, S. A. Woolson, Design
of orally active, non-peptidic inhibitors of human leukocyte elastase. J. Med.
40. C. A. Veale, P. R. Bernstein, C. M. Bohnert, F. J. Brown, C. Bryant, J. R.
Damewood Jr., R. Earley, S. W. Feeney, P. D. Edwards, B. Gomes, J. M. Hulsizer,
B. J. Kosmider, R. D. Krell, G. Moore, T. W. Salcedo, A. Shaw, D. S. Silberstein, G.
B. Steelman, M. Stein, A. Strimpler, R. M. Thomas, E. P. Vacek, J. C. Williams, D.
J. Wolanin, S. Woolson, Orally active trifluoromethyl ketone inhibitors of human
bromides.
Adv.
Synth.
Catal.
354,
1685–1691
(2012).
59. J. Hu, H. Sun, W. Cai, X. Pu, Y. Zhang, Z. Shi, Nickel-catalyzed borylation of aryl-
and benzyltrimethylammonium salts via C-N bond cleavage. J. Org. Chem. 81,
leukocyte
elastase.
J.
Med.
Chem.
40,
3173–3181
(1997).
41. P. R. Bernstein, B. C. Gomes, B. J. Kosmider, E. P. Vacek, J. C. Williams,
Nonpeptidic inhibitors of human leukocyte elastase. 6. Design of a potent,
intratracheally active, pyridone-based trifluoromethyl ketone. J. Med. Chem. 38,
42. J. P. Burkhart, J. R. Koehl, S. Mehdi, S. L. Durham, M. J. Janusz, E. W. Huber, M.
R. Angelastro, S. Sunder, W. A. Metz, P. W. Shum, T.-M. Chen, P. Bey, R. J.
Cregge, N. P. Peet, Inhibition of human neutrophil elastase. 3. An orally active
enol acetate prodrug. J. Med. Chem. 38, 223–233 (1995).
43. P. D. Edwards, D. W. Andisik, C. A. Bryant, B. Ewing, B. Gomes, J. J. Lewis, D.
Rakiewicz, G. Steelman, A. Strimpler, D. A. Trainor, P. A. Tuthill, R. C. Mauger, C.
A. Veale, R. A. Wildonger, J. C. Williams, D. J. Wolanin, M. Zottola, Discovery and
biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of
human neutrophil elastase. J. Med. Chem. 40, 1876–1885 (1997).
44. K. Hemmi, I. Shima, K. Imai, H. Tanaka, European patent EP0494071 (1992).
45. T. Kinoshita, I. Nakanishi, A. Sato, T. Tada, True interaction mode of porcine
pancreatic elastase with FR136706, a potent peptidyl inhibitor. Bioorg. Med.
46. F. von Nussbaum, V. M.-J. Li, Neutrophil elastase inhibitors for the treatment of
(cardio)pulmonary diseases: Into clinical testing with pre-adaptive
pharmacophores. Bioorg. Med. Chem. Lett. 25, 4370–4381 (2015).
60. A. Chen, L. Ren, C. M. Crudden, Catalytic asymmetric hydrocarboxylation and
hydrohydroxymethylation.
A two-step approach to the enantioselective
functionalization of vinylarenes. J. Org. Chem. 64, 9704–9710 (1999).
61. T. Furukawa, T. Akutagawa, H. Funatani, T. Uchida, Y. Hotta, M. Niwa, Y. Takaya,
Cyclic dipeptides exhibit potency for scavenging radicals. Bioorg. Med. Chem.
62. D. L. Boger, S. Miyazaki, O. Loiseleur, R. T. Beresis, S. L. Castle, J. H. Wu, Q. Jin,
Thermal atropisomerism of aglucovancomycin derivatives: Preparation of
(M,M,M)- and (P,M,M)-aglucovancomycins. J. Am. Chem. Soc. 120, 8920–8926
63. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow
Aerobically—Ninth Edition (Clinical and Laboratory Standards Institute, 2012).
64. S. Kokinaki, L. Leondiadis, N. Ferderigos, A novel and efficient method for
cleavage of phenacylesters by magnesium reduction with acetic acid. Org. Lett.
65. T. Miyazawa, S. Hiramatsu, Y. Tsuboi, T. Yamada, S. Kuwata, Studies of unusual
amino acids and their peptides. XVII. The synthesis of peptides containing N-
carboxymethyl amino acids. II. Bull. Chem. Soc. Jpn. 58, 1976–1982 (1985).
66. J. Liu, K. R. West, C. R. Bondy, J. K. M. Sanders, Dynamic combinatorial libraries
of hydrazone-linked pseudo-peptides: Dependence of diversity on building block
First release: 13 April 2017
(Page numbers not final at time of first release)
6